The tumor suppressor LACTB remodels mitochondria to promote cytochrome c release and apoptosis
Science Advances · 14.11.2025 · 11 (46)
DOI: 10.1126/sciadv.adx7809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.11.2025. Verfasst von Sukrut C Kamerkar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA. Hauptthemen laut MEDLINE: Apoptosis, Mitochondria, Cytochromes c, Tumor Suppressor Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Mitochondria are pivotal regulators of cellular homeostasis, integrating energy metabolism, biosynthesis, and programmed cell death (apoptosis). During apoptosis, mitochondrial outer membrane permeabilization by BCL-2-associated X protein/BCL-2 Homolog Antagonist Killer (BAX/BAK) pores facilitates release of apoptotic factors, while the role of inner mitochondrial membrane (IMM) remodeling remains less understood. Here, we identify serine beta-lactamase-like protein (LACTB), a filament-forming serine protease and tumor suppressor, as a regulator of IMM dynamics during apoptosis. LACTB suppression reduces cytochrome c release and apoptosis, whereas its overexpression promotes these effects. LACTB does not affect BAX or Drp1 recruitment to mitochondria. Rather, LACTB is required for apoptosis-induced mitochondrial remodeling, independent of OPA1 processing. Intriguingly, LACTB knockdown does not affect mitochondrial shape changes induced by CCCP treatment, suggesting that LACTB action is apoptosis-specific. Purified LACTB binds and remodels cardiolipin-enriched membrane nanotubes preferentially over planar lipid membranes, suggesting a direct effect in apoptotic membrane remodeling. Collectively, our findings suggest LACTB to be a mediator of apoptosis-induced IMM remodeling, a possible mechanism for tumor suppression in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
- Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA.
ORCID-Profile: Sukrut C Kamerkar, Taewook Kang, Edward J Usherwood, Henry N Higgs
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- Dartmouth College
Zitieren
APA
Kamerkar, S. C., Kang, T., Stan, R. V., Usherwood, E. J., & Higgs, H. N. (2025). The tumor suppressor LACTB remodels mitochondria to promote cytochrome c release and apoptosis. Science Advances, 11(46). https://doi.org/10.1126/sciadv.adx7809
Vancouver
Kamerkar SC, Kang T, Stan RV, Usherwood EJ, Higgs HN. The tumor suppressor LACTB remodels mitochondria to promote cytochrome c release and apoptosis. Science Advances. 2025;11(46). doi:10.1126/sciadv.adx7809
BibTeX
@article{Kamerkar2025,
author = {Kamerkar, Sukrut C and Kang, Taewook and Stan, Radu V and Usherwood, Edward J and Higgs, Henry N},
title = {The tumor suppressor LACTB remodels mitochondria to promote cytochrome c release and apoptosis},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {46},
doi = {10.1126/sciadv.adx7809}
}
EUVIMED